Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gholamreza Yousefzadeh"'
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 7, Iss 1, Pp n/a-n/a (2024)
Abstract Introduction Atherosclerotic cardiovascular diseases (ASCVD) are significant sources of mortality and morbidity with substantial economic implications and preventive measures play key roles in this regard. Metabolic syndrome (MetS) is a comm
Externí odkaz:
https://doaj.org/article/cde7d176c2c04f5b8a3a5ba0568ed5d7
Autor:
Seyedeh Mahdieh Khoshnazar, Hamid Najafipour, Lida SoltaniNejad, Sara Pezeshki, Gholamreza Yousefzadeh
Publikováno v:
Italian Journal of Medicine, Vol 17, Iss 2 (2023)
To control diabetes in a society, risk assessment tools are used to predict disease risk. We aimed to assess the value of different risk factors for diabetes mellitus in a remarkable community in the city of Kerman, one of the vast areas in the south
Externí odkaz:
https://doaj.org/article/ebd97890d36e4192a0cf92b50de4cdbd
Publikováno v:
Diabetes & Metabolism Journal, Vol 41, Iss 1, Pp 31-37 (2017)
BackgroundThe aim of this study was to evaluate the safety and effectiveness of insulin glargine in a large population from a variety of clinical care in Iranian people with type 2 diabetes mellitus (T2DM) and to measure the percentage of patients ac
Externí odkaz:
https://doaj.org/article/e83389aa968f4d2f9fcb8bb7af5f58fb
Autor:
Hamid Najafipour, Gholamreza Yousefzadeh, Mohammad Reza Baneshi, Milad Ahmadi Gohari, Beydolah Shahouzehi, Mitra Shadkam Farokhi, Ali Mirzazadeh
Publikováno v:
Journal of Research in Medical Sciences, Vol 26, Iss 1, Pp 99-99 (2021)
Background: Dyslipidemia (DL) is an important risk factor of coronary artery disease (CAD). We evaluated DL prevalence and its 5-year incidence rate in southeastern Iran, to assess the severity and growth rate of this CAD risk factor in the region. M
Externí odkaz:
https://doaj.org/article/bae5aaa271ad4d5087ce808c183bcf93
Autor:
Hamid Najafipour, Gholamreza Yousefzadeh, Afsaneh Forood, Mohammad Karamouzian, Mitra Shadkam, Ali Mirzazadeh
Publikováno v:
ARYA Atherosclerosis, Vol 12, Iss 1, Pp 18-27 (2016)
BACKGROUND: The aim of this study was to present age-sex standardized prevalence of overweight and obesity as well as central obesity and its associated variables in an adult population of Iran. METHODS: Around 5900 adult individuals aged 15-75 years
Externí odkaz:
https://doaj.org/article/9e575e63a45f4850a0bca70189e30627
Autor:
Fatemeh Safavi, Gholamreza Yousefzadeh, Mostafa Shokoohi, Sadaf Safavi, Hamid Najafipour, Mitra Shadkam Farokhi
Publikováno v:
Journal of Kerman University of Medical Sciences, Vol 22, Iss 3, Pp 229-239 (2015)
Background & Aims: Metabolic syndrome is composed of interrelated cardiovascular and cardiometabolic risk factors. Moreover, recent researches have illustrated the association of systemic diseases and periodontitis. Thus, the early diagnosis of this
Externí odkaz:
https://doaj.org/article/855560fb96ef494bba93ec08ece929b6
Publikováno v:
International Journal of Health Policy and Management, Vol 4, Iss 5, Pp 271-277 (2015)
Background The goal of diabetes control should be feasible in order to minimize the risk of its adverse events and to reduce its burden and cost on patients. The current study aimed to assess the status of glycemic control in male and female patients
Externí odkaz:
https://doaj.org/article/7afe5f36f0c14adf8e75e2b62cee9b0c
Publikováno v:
ARYA Atherosclerosis, Vol 11, Iss 3, Pp 179-185 (2015)
BACKGROUND: There has been a few studies about the predictability of metabolic syndrome (MetS) based on the Framingham risk score (FRS) as a tool for predicting the risk of 10-years cardiovascular diseases (CVD) in Iranian population. The aim of this
Externí odkaz:
https://doaj.org/article/a3ac02d8e4e44222bdcae5cdbea4ec13
Publikováno v:
ARYA Atherosclerosis, Vol 11, Iss 1, Pp 14-20 (2015)
BACKGROUND: Along with the established effects of opium on metabolic parameters, stimulatory or inhibitory effects of opium on metabolic syndrome are also predictable. This study aimed to examine the association of opium use with metabolic syndrome a
Externí odkaz:
https://doaj.org/article/43430b2171424187977f6be76ea7d75c
Autor:
Gholamreza Yousefzadeh, Fatameh Mahdavi-Jafari, Mostafa Shokoohi, Hamid Najafipour, Ali-Akbar Haghdoost, Vida Modares-Nejad
Publikováno v:
ARYA Atherosclerosis, Vol 9, Iss 6, Pp 332-336 (2013)
BACKGROUND: Menopause is now viewed as a risk factor for coronary heart diseases (CHD). There is a scarcity of evidence concerning the effects of menopause on coronary artery disease (CAD) risk factors. The present study aimed to evaluate the effects
Externí odkaz:
https://doaj.org/article/ff5299e4c4e9489c9c2fe7cf53c65a0a